From tar­geted drug delivery mech­a­nisms to super­sen­si­tive imaging tech­niques, nan­otech­nology holds many promises for med­i­cine. But advances taking place in the research lab will help few patients without suc­cessful trans­la­tion into clin­ical and com­mer­cial envi­ron­ments, said Srinivas Sridhar, Dis­tin­guished Pro­fessor of Physics and director the Nanomed­i­cine IGERT Center, an Inte­gra­tive Grad­uate Edu­ca­tion and Research Trainee­ship jointly funded by the National Sci­ence Foun­da­tion and the National Cancer Institute.

Full article